Non Small Cell Lung Cancer Clinical Trials Database - Free Access to 564 Studies
Access comprehensive clinical trial information for Non Small Cell Lung Cancer through Pure Global AI's free database. This collection includes 564 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 113 trials are actively recruiting participants.
Research for Non Small Cell Lung Cancer is being conducted in China, United States of America, France and 7+ other countries. Leading sponsors include Eli Lilly and Company and AstraZeneca. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
TOP 2301: Neoadjuvant Chemo for NSCLC
DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC
Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor Failure
Radiomics and Radiogenomics of Non-small Cell Lung Cancer
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
TGRX-326 Phase I/II Pharmacokinetic Study
Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X)
D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure
TGRX-326 Pharmacokinetic Drug Interaction
A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.
Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations
Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases
Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects
A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors
Addition of Hypofractionated High Dose Radiation in Oligometastatic Disease
Molecular Diagnosis of Lung Cancer Via Bronchoscopy: The Significance of Bronchial Liquid Biopsy (ctDNA and ctRNA)
Tumor Treating Fields for Locally Advanced NSCLC
A Study to Explore the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients
The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC
TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC)
Pure Global AI provides free access to 564 clinical trials studying Non Small Cell Lung Cancer, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Eli Lilly and Company, AstraZeneca, Hunan Province Tumor Hospital, among others.